72.11.Z - Research and experimental development on biotechnology
32.50.Z - Manufacture of medical and dental instruments and supplies
47.91.Z - Retail sale via mail order houses or via Internet
47.99.Z - Other retail sale not in stores, stalls or markets
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
75.00.Z - Veterinary activities
77.39.Z - Rental and leasing of other machinery, equipment and tangible goods not elsewhere classified
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.90.E - Other human health activities notelsewhere classified
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,3 | 0,5 | 9,6 | 1704,9 |
EBITDA | 0,7 | 4 | 10,4 | 160,9 |
Short time liabilities | 2,1 | 5,6 | 5 | -9,6 |
Equity capital | 2,5 | 1,9 | 9,1 | 380,2 |
Operating profit (EBIT) | -0,2 | 0,8 | 9,5 | 1157,8 |
Assets | 16,1 | 9,7 | 15,5 | 60,5 |
Net profit (loss) | -0,3 | 0,3 | 7,2 | 2025,1 |
Cash | 0 | 0,3 | 3,7 | 1321 |
Liabilities and provisions for liabilities | 13,6 | 7,8 | 6,4 | -17 |
Net income from sale | 1,1 | 4,2 | 29,3 | 597,4 |
Working assets | 2,2 | 6 | 12,7 | 111,4 |
Depreciation | 0,9 | 3,2 | 0,8 | -74 |
% | % | % | p.p. | |
Profitability of capital | -10,5 | 18 | 79,7 | 61,7 |
Equity capital to total assets | 15,6 | 19,5 | 58,4 | 38,9 |
Gross profit margin | -23,6 | 12,6 | 32,6 | 20 |
EBITDA Margin | 59,7 | 94,5 | 35,4 | -59,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 672 | 482 | 62 | -420 |
Current financial liquidity indicator | 0.7786543369293213 | 1.9655975103378296 | 1,2 | |
Net dept to EBITDA | 0.6149010062217712 | -0.25062480568885803 | -0,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane